Unitaid
room Chemin de Blandonnet 10 – BIBC III – 8th Floor 1214 Vernier, Switzerland
arrow_back See all Activities

A randomised trial to compare dolutegravir + pharmaco-enhanced darunavir versus recommended standard of care antiretroviral regimens in patients with HIV infection who have failed recommended first-line therapy

IATI Identifier:

Published on IATI
  • date_range Jan 01, 2017 - Dec 31, 2020
  • autorenew Implementation (Status)

The project goal is to contribute to scale-up of improved second-line ARV treatment.

more_horiz

Participating Organisations

UNIVERSITY OF NEW SOUTH WALES – KIRBY INSTITUTE Academic, Training and Research Implementing

Transaction

Transaction Value Provider
Receiver 		Type Date
Not Available Provider N/A Receiver N/A
date_range
Not Available Provider N/A Receiver N/A
date_range
Not Available Provider N/A Receiver N/A
date_range
Not Available Provider N/A Receiver N/A
date_range
Not Available Provider N/A Receiver N/A
date_range
Not Available Provider N/A Receiver N/A
date_range
Not Available Provider N/A Receiver N/A
date_range
Not Available Provider N/A Receiver N/A
date_range
Not Available Provider N/A Receiver N/A
date_range
Not Available Provider N/A Receiver N/A
date_range
Not Available Provider N/A Receiver N/A
date_range

Budget

10,319,153 USD
  • 1,184,030 USD (Valued at Oct 17, 2022)
    date_range Jan 01, 2017 - Dec 31, 2017
  • 1,419,460 USD (Valued at Oct 17, 2022)
    date_range Jan 01, 2018 - Dec 31, 2018
  • 1,903,740 USD (Valued at Dec 31, 2020)
    date_range Jan 01, 2019 - Dec 31, 2019
  • 2,089,181 USD (Valued at Oct 17, 2022)
    date_range Jan 01, 2020 - Dec 31, 2020
  • 1,641,921 USD (Valued at Oct 17, 2022)
    date_range Jan 01, 2021 - Dec 31, 2021
  • 2,080,821 USD (Valued at Oct 17, 2022)
    date_range Jan 01, 2022 - Dec 31, 2022
access_time Updated on Oct 17, 2022 14:09:42